相关实验视频

Updated: May 11, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

在5xFAD小鼠中,Apolipoprotein E4干扰脂质代谢,加剧类似抑郁症的行为

Yanju Gong¹, Mingfeng Li¹, Min Liu¹

¹iNHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, International Center for Technology and lnnovation of Animal Model, Comparative Medicine Center, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PuMC), Beijing, China.

Animal models and experimental medicine

|June 19, 2024

概括

脂蛋白E4 (ApoE4) 在阿尔茨海默病 (AD) 模型中加剧抑郁症和认知衰退,与脂质代谢中断有关. 向脂质平衡可能为患有抑郁症的阿尔茨海默病提供新的治疗途径.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
代谢障碍代谢障碍代谢障碍

背景情况:

阿波利波蛋白E4 (ApoE4) 基因是晚发性阿尔茨海默病 (AD) 的重要遗传风险因素.
已知ApoE4可使非AD患者的抑郁症状恶化.
ApoE4对AD相关抑郁症类行为及其机制的具体影响尚未完全理解.

研究的目的:

在5xFAD小鼠模型中研究ApoE4过度表达对类似抑郁症的行为和认知功能的影响.
阐明潜在的致病机制,包括脂质代谢和神经递质变化.
为研究AD与抑郁症并发症提供一个合适的动物模型.

主要方法:

开发了一个5xFAD小鼠模型,过度表达人类ApoE4 (E4FAD).
进行行为,突触功能和神经递质 (血清素,GABA) 评估.
分析了周围和中心脂质代谢,以及关键的分子通路 (DHCR24/GSK3β/mTOR,PSD95/CaMK-II/BDNF).

主要成果:

与5xFAD小鼠相比,E4FAD小鼠表现出更严重的类似抑郁症的行为和认知障碍.
在E4FAD小鼠中观察到粉样β沉积增加,星细胞数量增加,并降低了5-HT/GABA水平.
确定了重要的脂质代谢障碍和关键分子通路中的蛋白质表达异常.

结论:

在AD小鼠中,ApoE4过度表达会恶化类似抑郁症的行为和认知缺陷.
中央和外周脂质代谢障碍与ApoE4的致病机制有关.
调节ApoE以恢复脂质平衡是一种潜在的治疗策略,用于AD与抑郁症并发症.

关键词:

在5xFAD小鼠中.阿尔茨海默氏症的疾病是阿尔茨海默氏症.在 ApoE4 的代基因中,像抑郁症这样的抑郁症.

更多相关视频

Animal Models of Depression - Chronic Despair Model CDM

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

Strategies for Assessing Autistic-Like Behaviors in Mice

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...